This resulted from the combined effects involving the PEF and CP to inactivate the lipoxygenase, the antioxidant activity associated with the polyphenols present in the 1% SLE solution, as well as the impact of the selected MAP3 deficient in oxygen. This evidence concerns the gene CP and systemic lupus erythematosus.